Infrequent p53 gene mutations in medulloblastomas.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Cancer Research

• Publication date

  1991-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 1873817
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• p53 mutations in human cancers.

  1991cited by this paper
• Loss of heterozygosity on 6q, 16q, and 17p in human central nervous system primitive neuroectodermal tumors.

  1991cited by this paper
• Identification of p53 gene mutations in bladder cancers and urine samples.

  1991cited by this paper
• Oncogene amplification in pediatric brain tumors.

  1990cited by this paper
• Successful laboratory growth and analysis of CUSA-obtained medulloblastoma samples. Technical note.

  1990cited by this paper
• Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts.

  1990cited by this paper
• Reduction to homozygosity and gene amplification in central nervous system primitive neuroectodermal tumors of childhood.

  1990cited by this paper
• Deletion mapping of the medulloblastoma locus on chromosome 17p.

  1990cited by this paper
• Loss of genetic information in central nervous system tumors common to children and young adults

  1990cited by this paper
• Cytogenetics of human brain tumors.

  1990cited by this paper
• Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis.

  1990cited by this paper
• Isochromosome 17q in primitive neuroectodermal tumors of the central nervous system

  1989cited by this paper
• Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.

  1989cited by this paper
• Mutations in the p53 gene occur in diverse human tumour types

  1989cited by this paper
• Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus.

  1988cited by this paper
• Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc.

  1988cited by this paper
• Establishment of a Human Medulloblastoma Cell Line and Its Heterotransplantation into Nude Mice

  1985cited by this paper
• Establishment and Characterization of the Human Medulloblastoma Cell Line and Transplantable Xenograft D283 Med

  1985cited by this paper
• Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.

  1984cited by this paper
• Pathology of Tumours of the Nervous System

  1960cited by this paper

• Comparative analysis of pediatric SHH medulloblastoma DAOY spheres and adherent monolayers: implications for medulloblastoma research

  2025cites this paper
• The pivotal role of irradiation‐induced apoptosis in the pathogenesis and therapy of medulloblastoma

  2024cites this paper
• Medulloblastoma: From TP53 Mutations to Molecular Classification and Liquid Biopsy

  2023cites this paper
• Lestaurtinib inhibits Citron kinase activity and medulloblastoma growth through induction of DNA damage, apoptosis and cytokinesis failure

  2023influential citation
• Cell-free DNA as a biomarker in cancer

  2022cites this paper
• Differential regulation of p27Kip1 depending on culture conditions and its correlation with status of p14ARF and p53

  2022cites this paper
• Liquid biopsy for monitoring medulloblastoma

  2022cites this paper
• Medulloblastoma and the DNA Damage Response

  2022cites this paper
• Liquid Biopsy and Primary Brain Tumors

  2021cites this paper
• PPM1D Is a Therapeutic Target in Childhood Neural Tumors

  2021cites this paper
• Concomitant targeting of Hedgehog signaling and MCL-1 synergistically induces cell death in Hedgehog-driven cancer cells.

  2019cites this paper
• RITA downregulates Hedgehog-GLI in medulloblastoma and rhabdomyosarcoma via JNK-dependent but p53-independent mechanism.

  2019cites this paper
• Selective BCL-XL inhibition promotes apoptosis in combination with MLN8237 in medulloblastoma and pediatric glioblastoma cells

  2018cites this paper
• Elucidating the role of TGFβ signalling in drug resistant Hh driven cancers

  2018cites this paper
• Hedgehog signaling negatively co-regulates BH3-only protein Noxa and TAp73 in TP53-mutated cells.

  2018cites this paper
• Polo-Like Kinase 1 Pharmacological Inhibition as Monotherapy or in Combination: Comparative Effects of Polo-Like Kinase 1 Inhibition in Medulloblastoma Cells.

  2017cites this paper
• RITA displays anti-tumor activity in medulloblastomas independent of TP53 status

  2017cites this paper
• Untersuchung des Effektes von RITA auf das Wachstum von Medulloblastomzellen

  2016cites this paper
• In vitro models of medulloblastoma: Choosing the right tool for the job.

  2016cites this paper
• Cerebellum Development and Tumorigenesis: A p53-Centric Perspective.

  2016cites this paper
• Enhanced inhibition of clonogenic survival of human medulloblastoma cells by multimodal treatment with ionizing irradiation, epigenetic modifiers, and differentiation-inducing drugs

  2016cites this paper
• Evasion of cell senescence in SHH medulloblastoma

  2016cites this paper
• eview n vitro models of medulloblastoma : Choosing the right tool for the job

  2016cites this paper
• Molecular Biology and Genetics of Medulloblastoma

  2015cites this paper
• Tumors of the Posterior Fossa in Children

  2015cites this paper
• MicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknown

  2015cites this paper
• Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer.

  2014cites this paper
• The role of immunohistochemistry in the diagnosis of flat urothelial lesions: a study using CK20, CK5/6, P53, Cd138, and Her2/Neu.

  2014cites this paper
• The rationale for targeted therapies in medulloblastoma.

  2014cites this paper
• The Transcription Factor Cux1 in Cerebellar Granule Cell Development and Medulloblastoma Pathogenesis

  2014cites this paper
• Developmental Origins of Aggressive Medulloblastoma

  2013cites this paper
• Primary Tumors of the Nervous System

  2013cites this paper
• Biomarkers As Indicators Of Severity Of Cerebral Damage In Postoperative Brain Tumor Patients

  2013cites this paper
• Inhibitory effects of epigenetic modulators and differentiation inducers on human medulloblastoma cell lines

  2013cites this paper
• Chemical biology approaches for the identification of novel p53 regulatory signalling pathways

  2013cites this paper
• PCAF ubiquitin ligase activity inhibits Hedgehog/Gli1 signaling in p53-dependent response to genotoxic stress

  2013cites this paper
• Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas.

  2012cites this paper
• Blockade of SOX4 mediated DNA repair by SPARC enhances radioresponse in medulloblastoma.

  2012cites this paper
• Prognostic and Therapeutic Implications of Biological Behavior of TP53 Mutations in WNT and Sonic-Hedgehog Medulloblastomas

  2012cites this paper
• WIP1 Enhances Tumor Formation in a Sonic Hedgehog–Dependent Model of Medulloblastoma

  2012cites this paper
• HDM2 promotes WIP1-mediated medulloblastoma growth.

  2012cites this paper
• Molecular Mechanisms of Chemoresistance in Medulloblastoma

  2012cites this paper
• miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma.

  2011cites this paper
• p53 in the CNS: Perspectives on Development, Stem Cells, and Cancer.

  2011cites this paper
• Central nervous system

  2011cites this paper
• Reply to J.C. Lindsey et al

  2011cites this paper
• Docosahexaenoic acid (DHA) sensitizes brain tumor cells to etoposide-induced apoptosis.

  2011cites this paper
• UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53

  2011cites this paper
• The Genetic Landscape of the Childhood Cancer Medulloblastoma

  2011cites this paper
• The microtubule stabilizer patupilone (epothilone B) is a potent radiosensitizer in medulloblastoma cells.

  2011cites this paper
• The Potential Role of Environmental Exposures and Genomic Signaling in Development of Central Nervous System Tumors

  2011cites this paper
• c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients

  2011cites this paper
• Progress in sequencing human cancer genomes: advancements in childhood medulloblastoma.

  2011cites this paper
• Alvos moleculares em meduloblastoma : um estudo in vitro

  2010cites this paper
• TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma.

  2010cites this paper
• TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors.

  2010cites this paper
• p53 regulates LIF expression in human medulloblastoma cells

  2010cites this paper
• Universal poor survival in children with medulloblastoma harboring somatic TP53 mutations.

  2010cites this paper
• Targeted Therapy in Medulloblastoma in Molecularly Targeted Therapy for Childhood Cancer

  2010cites this paper
• Recent therapeutic advances for treating medulloblastoma: focus on new molecular targets.

  2010cites this paper
• Mouse models of CNS embryonal tumors

  2009cites this paper
• RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells

  2009cites this paper
• Apoptotic Proteins and Markers of Differentiation in Childhood Pineal Parenchymal Tumors: Relationships and Prognostic Value

  2009cites this paper
• Embryonal neural tumours and cell death

  2009cites this paper
• Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo.

  2009cites this paper
• An immunohistochemical and microsatellite analysis of nephroblastomas.

  2008cites this paper
• Biological Markers in Pediatric Brain Tumors

  2008cites this paper
• Microsoft Word - PNE226BF.rtf

  2008cites this paper
• c-Myc and β-catenin cooperate with loss of p53 to generate multiple members of the primitive neuroectodermal tumor family in mice

  2008cites this paper
• Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective.

  2008cites this paper
• Medulloblastoma, Primitive Neuroectodermal Tumors, and Pineal Tumors

  2008cites this paper
• Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells

  2007cites this paper
• Molecular Genetic Analysis of Oligodendroglial Tumors Shows Preferential Allelic Deletions on 19 q and 1 p

  2007cites this paper
• Overexpressed TP73 induces apoptosis in medulloblastoma

  2007cites this paper
• Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D

  2007cites this paper
• FOXG1 dysregulation is a frequent event in medulloblastoma

  2007cites this paper
• Mutations in Human Malignant Gliomas : Comparison of Loss of Heterozygosity with Mutation Frequency 1

  2006cites this paper
• Mutations of the p 53 Gene Do Not Occur in Testis Cancer 1

  2006cites this paper
• Chemotherapy of Medulloblastoma

  2006cites this paper
• IDENTIFICATION OF GENES THAT COOPERATE WITH P53 IN TUMORIGENESIS

  2006cites this paper
• Genetic mapping of a putative tumor suppressor locus that influences tumorigenesis and metastasis in mice

  2006cites this paper
• p 53 Gene Mutation and mdm 2 Gene Amplification Are Uncommon in Medulloblastomat

  2006cites this paper
• Absence of p 53 Gene Mutations in Primary Neuroblastomas 1

  2006cites this paper
• Array CGH analysis of pediatric medulloblastomas

  2006cites this paper
• Advances in Brief Identification of Two Candidate Tumor Suppressor Genes on Chromosome I 7 pl 3 . 3 l

  2006cites this paper
• Gene Mutations in Primary Neuroblastomas p 53 Absence of Updated Version

  2006cites this paper
• Loss of Heterozygosity with Mutation Frequency p 53 Mutations in Human Malignant Gliomas : Comparison of Updated

  2006cites this paper
• Review Article - Medulloblastomas: New directions in risk stratification

  2006cites this paper
• Medulloblastomas: new directions in risk stratification.

  2006cites this paper
• Avaliação molecular do gene supressor de tumor PTEN em tumores do sistema nervoso

  2006cites this paper
• Recent advances in embryonal tumours of the central nervous system

  2005cites this paper
• Cytogenetics and molecular genetics of childhood brain tumors 1

  2005cites this paper
• Molecular Pathology of Nervous System Tumors

  2005cites this paper
• Prognostic implications of chromosome 17p deletions in human medulloblastomas

  2005cites this paper
• Modeling medulloblastoma with genetically engineered mice.

  2005cites this paper
• Molecular Biology of Medulloblastoma: Will It Ever Make a Difference to Clinical Management?

  2005cites this paper
• Increased p53 immunopositivity in anaplastic medulloblastoma and supratentorial PNET is not caused by JC virus

  2005cites this paper
• Genetic analysis of p53 and RB1 tumor-suppressor genes in blast crisis of chronic myeloid leukemia

  2005cites this paper
• Genetic and Expression Profiles of Cerebellar Liponeurocytomas

  2004cites this paper
• Pediatric Medulloblastoma: Prognostic Value of p53, bcl-2, Mib-1, and Microvessel Density

  2004cites this paper